SUVEN PHARMACEUTICALS
Quarterly Results Analysis [Dec2024]
SUVEN PHARMACEUTICALS Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹307 Cr | ₹258 Cr | ₹231 Cr | ₹253 Cr | ₹220 Cr | ₹231 Cr | ₹348 Cr | ₹369 Cr |
Expenses | ₹189 Cr | ₹154 Cr | ₹151 Cr | ₹180 Cr | ₹154 Cr | ₹132 Cr | ₹180 Cr | ₹197 Cr |
Operating Income | ₹118 Cr | ₹104 Cr | ₹80 Cr | ₹73 Cr | ₹66 Cr | ₹99 Cr | ₹168 Cr | ₹172 Cr |
Other Income | ₹16 Cr | ₹14 Cr | ₹18 Cr | ₹17 Cr | ₹14 Cr | ₹20 Cr | ₹11 Cr | ₹11 Cr |
Interest | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹5 Cr |
Depreciation | ₹20 Cr | ₹17 Cr | ₹13 Cr | ₹17 Cr | ₹13 Cr | ₹12 Cr | ₹13 Cr | ₹12 Cr |
Profit Before Tax | ₹110 Cr | ₹100 Cr | ₹83 Cr | ₹71 Cr | ₹65 Cr | ₹105 Cr | ₹164 Cr | ₹166 Cr |
Profit After Tax | ₹83 Cr | ₹82 Cr | ₹61 Cr | ₹53 Cr | ₹47 Cr | ₹80 Cr | ₹121 Cr | ₹124 Cr |
EPS | ₹3.26 | ₹3.23 | ₹2.39 | ₹2.10 | ₹1.84 | ₹3.12 | ₹4.74 | ₹4.87 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUVEN PHARMACEUTICALS | -0.1% | -1% | 77% |
SUN PHARMACEUTICAL INDUSTRIES | 2.8% | -7.5% | 2.3% |
DIVIS LABORATORIES | -0.2% | -9.9% | 60.4% |
CIPLA | 4.4% | -0.6% | -1% |
TORRENT PHARMACEUTICALS | 4.8% | -2.9% | 15.4% |
DR REDDYS LABORATORIES | NA | -9.4% | -10.2% |
MANKIND PHARMA | -0.7% | -8.8% | 7.1% |
ZYDUS LIFESCIENCES | 2.5% | -11.4% | -5.5% |
LUPIN | 2.9% | -8.1% | 20.9% |
SUVEN PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 19.18 % |
Y-o-Y | 39.73 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹307 Cr | 19.18 | |
Sep2024 | ₹258 Cr | 11.72 | |
Jun2024 | ₹231 Cr | -8.79 | |
Mar2024 | ₹253 Cr | 15.06 | |
Dec2023 | ₹220 Cr | -4.86 | |
Sep2023 | ₹231 Cr | -33.52 | |
Jun2023 | ₹348 Cr | -5.90 | |
Mar2023 | ₹369 Cr | - |
SUVEN PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 13.16 % |
Y-o-Y | 78.12 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹118 Cr | 13.16 | |
Sep2024 | ₹104 Cr | 30.13 | |
Jun2024 | ₹80 Cr | 8.98 | |
Mar2024 | ₹73 Cr | 10.99 | |
Dec2023 | ₹66 Cr | -33.01 | |
Sep2023 | ₹99 Cr | -41.20 | |
Jun2023 | ₹168 Cr | -2.39 | |
Mar2023 | ₹172 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -5.05 % |
Y-o-Y | 27.48 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 38.32% | -5.05 | |
Sep2024 | 40.36% | 16.48 | |
Jun2024 | 34.65% | 19.48 | |
Mar2024 | 29% | -3.53 | |
Dec2023 | 30.06% | -29.59 | |
Sep2023 | 42.69% | -11.56 | |
Jun2023 | 48.27% | 3.74 | |
Mar2023 | 46.53% | - |
SUVEN PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 1.60 % |
Y-o-Y | 78.16 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹83 Cr | 1.60 | |
Sep2024 | ₹82 Cr | 34.90 | |
Jun2024 | ₹61 Cr | 13.86 | |
Mar2024 | ₹53 Cr | 14.17 | |
Dec2023 | ₹47 Cr | -41.23 | |
Sep2023 | ₹80 Cr | -34.04 | |
Jun2023 | ₹121 Cr | -2.72 | |
Mar2023 | ₹124 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -14.74 % |
Y-o-Y | 27.50 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 27.12 % | -14.74 | |
Sep2024 | 31.81 % | 20.77 | |
Jun2024 | 26.34 % | 24.83 | |
Mar2024 | 21.1 % | -0.80 | |
Dec2023 | 21.27 % | -38.22 | |
Sep2023 | 34.43 % | -0.78 | |
Jun2023 | 34.7 % | 3.40 | |
Mar2023 | 33.56 % | - |
SUVEN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 0.93 % |
Y-o-Y | 77.17 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹3.26 | 0.93 | |
Sep2024 | ₹3.23 | 35.15 | |
Jun2024 | ₹2.39 | 13.81 | |
Mar2024 | ₹2.1 | 14.13 | |
Dec2023 | ₹1.84 | -41.03 | |
Sep2023 | ₹3.12 | -34.18 | |
Jun2023 | ₹4.74 | -2.67 | |
Mar2023 | ₹4.87 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD